Skip to search formSkip to main contentSkip to account menu

TAK-475

Known as: TAK 475, TAK475 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Lapaquistat Acetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Efficacy and Safety of Tadalafil 5 mg Once Daily for the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: A 2-Year Follow-Up
2018
2018
DESCRIPTION OF A MODEL FOR LESSON PLANNING ON PEACE EDUCATION IN TEACHER TRAINING
Aim. The aim of the research is to describe the model for lesson planning on peace education in teacher training. The used… 
2016
2016
Characterization of Transporters in the Hepatic Uptake of TAK-475 M-I, a Squalene Synthase Inhibitor, in Rats and Humans
Abstract TAK-475 (lapaquistat acetate) is a squalene synthase inhibitor and M-I is a pharmacologically active metabolite of TAK… 
2012
2012
Grønne tak. Resultater fra et kunnskapsinnhentingsprosjekt
2011
2011
A NON-LOCAL BOUNDARY VALUE PROBLEM WITH INTEGRAL CONDITIONS FOR A SECOND ORDER HYPERBOLIC EQUATION (Suatu Masalah Nilai Sempadan Tak-Setempat dengan Syarat Kamiran bagi Suatu Persamaan Hiperbolik…
In this paper, the classic solution of one-dimensional boundary value problem for a hyperbolic equation with non-classic boundary… 
2009
2009
Proč tak snadno-- : některé rodinné důvody sametové revoluce :sociologický esej
Review
2008
Review
2008
Current and Future Pharmacologic Options for the Management of Patients Unable to Achieve Low-Density Lipoprotein-Cholesterol Goals with Statins
Low-density lipoprotein-cholesterol (LDL-C) lowering is the mainstay of the current treatment guidelines in the management of… 
2006
2006
Abstract 1493: TAK-475, a Squalene Synthase Inhibitor, Improves Lipid Profile in Hyperlipidemic Subjects
1995
1995
Electronic Publishing at the American Astronomical Society
1991
1991
Masyarakat tak bernegara : kritik teori politik Islam
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)